Pipeline
Nonagen Therapeutics is developing a rich pipeline of candidate therapeutics and actively advancing our lead compound, NTC-001, through IND-enabling development.
Nonagen Therapeutics is developing a rich pipeline of candidate therapeutics and actively advancing our lead compound, NTC-001, through IND-enabling development.
